ORPH NASDAQ
Orphazyme A/S
1W: -2.5%
1M: -29.3%
3M: -65.3%
1Y: -89.6%
$0.87
Last traded 2022-03-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$27K
+99.9% ▲
Net Income
-$26M
+76.4% ▲
EPS (Diluted)
$-0.74
+76.4% ▲
EBITDA
-$26M
+35.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $36M | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | -100.0% | +0.0% |
| Cost of Revenue | $4M | $5M | $18M | $782K | $0 |
| Gross Profit | -$4M | -$5M | $18M | -$782K | $0 |
| Gross Margin | — | — | 50.0% | — | — |
| R&D Expenses | $285M | $261M | $230M | $0 | $0 |
| SG&A Expenses | $50M | $342M | $421M | $40M | $13K |
| Operating Expenses | $336M | $609M | $669M | $40M | $27K |
| Operating Income | -$336M | -$609M | -$633M | -$41M | -$27K |
| Operating Margin | — | — | -1749.8% | — | — |
| Interest Expense | $5M | $14M | $9M | $0 | $0 |
| Income Before Tax | -$343M | -$635M | -$631M | -$41M | -$26K |
| Tax Expense | -$6M | -$2M | -$5M | -$3M | -$782 |
| Net Income | -$337M | -$633M | -$627M | -$111M | -$26M |
| Net Margin | — | — | -1731.1% | — | — |
| EPS (Diluted) | $-16.87 | $-22.32 | $-17.94 | $-3.14 | $-0.74 |
| EBITDA | -$334M | -$616M | -$604M | -$40M | -$26M |
| Shares Outstanding | 20M | 28M | 35M | 35M | 35M |